À¶Ý®ÊÓÆµ

2nd Circ. Backs Ex-Pfizer Worker's Insider Trading Conviction

By Dorothy Atkins ( September 5, 2025, 8:41 PM EDT) -- The Second Circuit on Friday affirmed a former Pfizer Inc. statistician's insider trading conviction for making $272,000 in options trades from nonpublic news about the success of trials for the COVID-19 therapy drug Paxlovid, rejecting his arguments that prosecutors improperly shifted their legal theory at trial and pursued the case in the wrong venue....

À¶Ý®ÊÓÆµ is on it, so you are, too.

A À¶Ý®ÊÓÆµ subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A À¶Ý®ÊÓÆµ subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience À¶Ý®ÊÓÆµ today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login